BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16797200)

  • 1. Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA).
    Kortekaas J; Müller SA; Ringler P; Gregorini M; Weynants VE; Rutten L; Bos MP; Tommassen J
    Microbes Infect; 2006 Jul; 8(8):2145-53. PubMed ID: 16797200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region.
    Kortekaas J; Pettersson A; van der Biezen J; Weynants VE; van der Ley P; Poolman J; Bos MP; Tommassen J
    Vaccine; 2007 Jan; 25(1):72-84. PubMed ID: 16914236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB.
    Pettersson A; Kortekaas J; Weynants VE; Voet P; Poolman JT; Bos MP; Tommassen J
    Vaccine; 2006 Apr; 24(17):3545-57. PubMed ID: 16517031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression and refolding of an 80-kDa iron transporter from the outer membrane of Escherichia coli.
    Buchanan SK
    Biochem Soc Trans; 1999 Dec; 27(6):903-8. PubMed ID: 10830125
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
    Thompson EAL; Feavers IM; Maiden MCJ
    Microbiology (Reading); 2003 Jul; 149(Pt 7):1849-1858. PubMed ID: 12855736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine potential of meningococcal FrpB: studies on surface exposure and functional attributes of common epitopes.
    Ala'Aldeen DA; Davies HA; Borriello SP
    Vaccine; 1994 May; 12(6):535-41. PubMed ID: 7518627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding, purification and crystallization of the FrpB outer membrane iron transporter from Neisseria meningitidis.
    Saleem M; Prince SM; Patel H; Chan H; Feavers IM; Derrick JP
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Feb; 68(Pt 2):231-5. PubMed ID: 22298007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of Neisseria meningitidis to iron limitation.
    Pettersson A; Poolman JT; van der Ley P; Tommassen J
    Antonie Van Leeuwenhoek; 1997 Feb; 71(1-2):129-36. PubMed ID: 9049024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae.
    van der Ley P; van der Biezen J; Sutmuller R; Hoogerhout P; Poolman JT
    Microbiology (Reading); 1996 Nov; 142 ( Pt 11)():3269-74. PubMed ID: 8969523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
    Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR.
    Bidmos FA; Chan H; Praekelt U; Tauseef I; Ali YM; Kaczmarski EB; Feavers I; Bayliss CD
    PLoS One; 2015; 10(7):e0133855. PubMed ID: 26208277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
    Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
    Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT
    Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Neisseria surface protein A is a potential vaccine candidate against Neisseria meningitides serogroup B.
    Ying S; He J; Yu M; Zhang Y; Deng S; Zhang L; Xie M; Hu S
    Mol Med Rep; 2014 Sep; 10(3):1619-25. PubMed ID: 24926810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a molecular decoy to segregate transport from antigenicity in the FrpB iron transporter from Neisseria meningitidis.
    Saleem M; Prince SM; Rigby SE; Imran M; Patel H; Chan H; Sanders H; Maiden MC; Feavers IM; Derrick JP
    PLoS One; 2013; 8(2):e56746. PubMed ID: 23457610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of iron-regulated outer membrane proteins of Neisseria meningitidis with the RmpM (class 4) protein.
    Prinz T; Tommassen J
    FEMS Microbiol Lett; 2000 Feb; 183(1):49-53. PubMed ID: 10650201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refolding of the recombinant protein OmpA70 from Leptospira interrogans from inclusion bodies using high hydrostatic pressure and partial characterization of its immunological properties.
    Fraga TR; Chura-Chambi RM; Gonçales AP; Morais ZM; Vasconcellos SA; Morganti L; Martins EA
    J Biotechnol; 2010 Jul; 148(2-3):156-62. PubMed ID: 20450943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B.
    Sung JW; Hsieh SY; Lin CL; Leng CH; Liu SJ; Chou AH; Lai LW; Lin LH; Kwok Y; Yang CY; Chong P
    Vaccine; 2010 Nov; 28(51):8175-82. PubMed ID: 20937316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.